New Zealand markets closed

Abbott Laboratories (ABT)

NYSE - Nasdaq Real-time price. Currency in USD
Add to watchlist
113.66+0.18 (+0.16%)
At close: 04:00PM EDT
113.50 -0.16 (-0.14%)
After hours: 07:55PM EDT
Annual

Cash flow

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Cash flows from operating activities
Net income
5,723,000
5,723,000
6,933,000
7,071,000
4,495,000
Depreciation & amortisation
3,243,000
3,243,000
3,267,000
3,538,000
3,327,000
Stock-based compensation
644,000
644,000
685,000
640,000
546,000
Change in working capital
-2,475,000
-2,475,000
-1,519,000
-771,000
-892,000
Accounts receivable
-356,000
-356,000
-68,000
-383,000
-924,000
Inventory
-232,000
-232,000
-1,413,000
-456,000
-493,000
Accounts payable
-760,000
-760,000
420,000
1,288,000
1,766,000
Other working capital
5,059,000
5,059,000
7,804,000
8,648,000
5,724,000
Net cash provided by operating activities
7,261,000
7,261,000
9,581,000
10,533,000
7,901,000
Cash flows from investing activities
Investments in property, plant and equipment
-2,202,000
-2,202,000
-1,777,000
-1,885,000
-2,177,000
Acquisitions, net
-877,000
-877,000
0
-187,000
-42,000
Purchases of investments
-159,000
-159,000
-185,000
-173,000
-83,000
Sales/maturities of investments
43,000
43,000
152,000
77,000
10,000
Other investing activities
22,000
22,000
22,000
26,000
19,000
Net cash used for investing activities
-3,133,000
-3,133,000
-1,740,000
-2,008,000
-2,215,000
Cash flows from financing activities
Debt repayment
-2,498,000
-2,498,000
-753,000
-48,000
-1,333,000
Common stock repurchased
-1,227,000
-1,227,000
-3,795,000
-2,299,000
-403,000
Dividends paid
-3,556,000
-3,556,000
-3,309,000
-3,202,000
-2,560,000
Other financing activities
-
-
-
-
-11,000
Net cash used provided by (used for) financing activities
-7,091,000
-7,091,000
-7,636,000
-5,494,000
-2,779,000
Net change in cash
-2,986,000
-2,986,000
83,000
2,961,000
2,978,000
Cash at beginning of period
9,882,000
9,882,000
9,799,000
6,838,000
3,860,000
Cash at end of period
6,896,000
6,896,000
9,882,000
9,799,000
6,838,000
Free cash flow
Operating cash flow
7,261,000
7,261,000
9,581,000
10,533,000
7,901,000
Capital expenditure
-2,202,000
-2,202,000
-1,777,000
-1,885,000
-2,177,000
Free cash flow
5,059,000
5,059,000
7,804,000
8,648,000
5,724,000